The Minister of Health and Genpharm appealed a decision granting judicial review that quashed the extension of a cut-off date for generic drug submissions to the Ontario Drug Benefit Formulary.
The application judge had found the process procedurally unfair and ordered a new cut-off date, resulting in all five competing generic drug companies having their products listed.
The Court of Appeal dismissed both appeals as moot, finding that the new Formulary had already been published, the legal landscape had changed, and Genpharm's proposed future action for damages did not justify hearing the appeal on the merits.